Trial Summary
What is the purpose of this trial?This study will test whether giving nivolumab in combination with pemetrexed and either cisplatin or carboplatin before surgery is a safe and effective approach to treating resectable mesothelioma without delaying surgery.
Eligibility Criteria
This trial is for adults with resectable malignant pleural mesothelioma. Participants must have a performance status indicating they are relatively active, agree to contraception if of childbearing potential, and not be pregnant or breastfeeding. They should not have had prior chemo or immunotherapy for mesothelioma, no serious illnesses or other cancers requiring treatment, and no active hepatitis B/C or HIV.Inclusion Criteria
My surgeon believes my condition can be treated with surgery.
I can provide tissue samples for the study, either from previous procedures or by undergoing a new biopsy if safe.
You have a negative HIV blood test.
+10 more
Exclusion Criteria
Pregnant or lactating women
I have received chemotherapy or immunotherapy for mesothelioma.
I currently have lung inflammation.
+4 more
Participant Groups
The study tests the combination of Nivolumab (an immunotherapy drug) with chemotherapy drugs Pemetrexed and either Cisplatin or Carboplatin before surgery in patients with mesothelioma. It aims to determine if this approach is safe and effective without delaying surgical intervention.
1Treatment groups
Experimental Treatment
Group I: nivolumab with pemetrexed and cisplatin or carboplatinExperimental Treatment3 Interventions
Eligible patients will receive two cycles of neoadjuvant therapy with nivolumab 360 mg, pemetrexed 500 mg/m2, and cisplatin 75 mg/m2 or carboplatin AUC=5. Subsequently, they will undergo pleurectomy/decortication.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Memoral Sloan Kettering MonmouthMiddletown, NJ
Memoral Sloan Kettering Basking RidgeBasking Ridge, NJ
Memoiral Sloan Kettering Basking RidgeBasking Ridge, NJ
Memorial Sloan Kettering BergenMontvale, NJ
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
Bristol-Myers SquibbIndustry Sponsor